Skip to main content
. 2015 Oct 26;15:805. doi: 10.1186/s12885-015-1828-2

Fig. 4.

Fig. 4

Endogenous hypoxia markers and tumor hypoxia. PFHIF-1α versus HFPim, PFCAIX versus HFPim, and PFHIF-1α versus PFCAIX for CK-160 (a) and TS-415 (b) cervical carcinoma xenografts. Points, individual tumors